According to a Korean study, PCNSL patients expressed glucose transporter protein type 1 (GLUT1) in tumor tissues, and patients with > 20% GLUT1 positivity in lymphoma cells had shorter OS and more rapid disease progression [363]. The gene discussed is SLC2A1; the disease is neoplasm.